<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03269916</url>
  </required_header>
  <id_info>
    <org_study_id>SixthSunYetSen</org_study_id>
    <nct_id>NCT03269916</nct_id>
  </id_info>
  <brief_title>Fertility and Ovarian Reserve Function in the Patient With Inflammatory Bowel Disease</brief_title>
  <official_title>Fertility and Ovarian Reserve Function in the Patient With Inflammatory Bowel - a Cross-sectional Survey and Case Control Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sixth Affiliated Hospital, Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sixth Affiliated Hospital, Sun Yat-sen University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      ECCO consensus, the fertility would decline in activity inflammatory bowel disease(IBD),
      because of anus lesions and pelvic abscess, or who underwent surgery, especially in patients
      with ileal pouch anal anastomosis (IPAA) storage.The study on fertility in inflammatory bowel
      disease were almost epidemiological investigation, the lack of objective evaluation of
      fertility, and controversial.This study will explore the fertility, ovarian reserve function
      and the pregnancy outcomes in patients with IBD.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Anticipated">August 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The AMH of IBD patients is lower than that of healthy women</measure>
    <time_frame>1 month</time_frame>
    <description>AMH is used to assess ovarian reserve function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The E2 of IBD patients is lower than that of healthy women</measure>
    <time_frame>1 month</time_frame>
    <description>E2 is used to assess ovarian reserve function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The FSH of IBD patients is lower than that of healthy women</measure>
    <time_frame>1 month</time_frame>
    <description>FSH is used to assess ovarian reserve function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The AFC of IBD patients is lower than that of healthy women</measure>
    <time_frame>1 month</time_frame>
    <description>AFC is used to assess ovarian reserve function</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Fertility Disorders</condition>
  <condition>Ovarian Reserve Function</condition>
  <condition>Pregnancy Outcomes</condition>
  <arm_group>
    <arm_group_label>IBD patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IBD patients, 17-40 years old, female</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>17-40 years old , female, without any gynecological disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Anti Mueller hormone</intervention_name>
    <description>used to assess ovarian reserve parameters</description>
    <arm_group_label>IBD patients</arm_group_label>
    <arm_group_label>healthy control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Estrogen</intervention_name>
    <description>used to assess ovarian reserve parameters</description>
    <arm_group_label>IBD patients</arm_group_label>
    <arm_group_label>healthy control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Follicle-Stimulating Hormone</intervention_name>
    <description>used to assess ovarian reserve parameters</description>
    <arm_group_label>IBD patients</arm_group_label>
    <arm_group_label>healthy control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Antral alveolar cell count</intervention_name>
    <description>used to assess ovarian reserve parameters</description>
    <arm_group_label>IBD patients</arm_group_label>
    <arm_group_label>healthy control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Inflammatory bowel disease

          2. 17-40 years old

          3. female

        Exclusion Criteria:

          1. in pregnancy or lactation

          2. a drug that has been or is being used known to affect ovarian function, such as
             cyclophosphamide

          3. reproductive system diseases unrelated to disease or treatment of inflammatory bowel
             disease, such as hysterectomy, pelvic radiotherapy after surgery, after ovariectomy,
             polycystic ovary syndrome, endometriosis, ovarian granulosa cell tumor

          4. other endocrine diseases, such as prolactin, hyperthyroidism, lead to endocrine
             disorders;

          5. malignant tumor
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Min Zhi, PHD</last_name>
    <role>Study Chair</role>
    <affiliation>The Sixth Affiliated Hospital of Zhongshan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>xiang peng, MM</last_name>
    <phone>18302076916</phone>
    <email>stefaniepx@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Sixth Affiliated Hospital of Zhongshan University</name>
      <address>
        <city>GuangZhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>xiang peng, MM</last_name>
      <phone>18302076916</phone>
      <email>stefaniepx@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 13, 2017</study_first_submitted>
  <study_first_submitted_qc>August 29, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2017</study_first_posted>
  <last_update_submitted>August 29, 2017</last_update_submitted>
  <last_update_submitted_qc>August 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sixth Affiliated Hospital, Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>pengxiang</investigator_full_name>
    <investigator_title>Attending doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
    <mesh_term>Follicle Stimulating Hormone</mesh_term>
    <mesh_term>Estrogens</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

